Noting that EBITDA, adjusted for one time sales of company real estate etc, is up something like 3x over last year based on recent guidance I experimented by multiplying free cash flow by the same amount. This puts the multiple of MCAP/FCF at about 2. I hesitate on what to do about this as it means the company is incredibly cheap on all metrics, but I don’t know if I should be making these sorts of projections about FCF from a guidance announcement regarding EBITDA @TEPCapital @Strawman @Wini?
As shown in the latest announcement, 2022 EBITDA guidance is 6.7-8m. This represents astronomical OI/FDS CAGR of 58% from 2017-2022, the available range of data from IPO materials to latest 2022 guidance, considering that OI/FDS was only 0.0069 in 2017. Perhaps it's more realistic to start from 2018 when OI/FDS was 0.05, resulting in a CAGR of 8% from then to the lower bound of 2022 EBITDA guidance. Rough I know, especially considering that OI and EPITDA aren't equivalent. But at least this means OI geometric growth average will be positive.

What remains is that the OIROCE metrics will probably remain below that which the market index can achieve. Why bother buying a company that achieves a lower rate of return than the index? Why not just buy the index and forget about it?